Topera® (now Abbott Electrophysiology) began as the inspired story of one doctor’s unwavering commitment to improve the life of one of his arrhythmia patients. As a dedicated researcher at University of California, San Diego and a practicing cardiac electrophysiologist at the San Diego VA Medical Center, Dr. Sanjiv Narayan had a deep appreciation for heart rhythm disorders and their profound effect on the everyday lives of people.
When a patient, who had undergone three failed procedures to correct his atrial fibrillation (Afib), sought his advice, Dr. Narayan believed the solution was to first identify, then target the mechanism that was sustaining the patient’s Afib. Catheter ablation risks can increase in patients who undergo the procedure multiple times.
Using his own prototype version of the Focal Impulse and Rotor Modulation (FIRM) mapping software, Dr. Narayan, with the help of his colleague Dr. Ruchir Sehra, was able to identify a rotor in an area not usually targeted for treatment. A rotor is a rotational wave that drives surrounding disorganized activation and fibrillation. In their experience, if rotors were eliminated via cardiac ablation, Dr. Narayan noted enhanced procedure results. This breakthrough led to the development and validation of a novel diagnostic system to help identify the sources that sustain Afib and the eventual formation of Topera.
Topera was founded on a single, focused mission that still guides every aspect of the business today: To become the recognized global leader in identifying the sources of arrhythmias which enables patient-specific solutions.
Abbott acquired Topera in 2014 and created a new electrophysiology division committed to improving the diagnosis and treatment of Afib. Now called Abbott Electrophysiology or Abbott EP, this commitment to offer Afib and other arrhythmia patients more options will continue to expand worldwide. Abbott EP intends to solve one of the most critical and unmet needs in cardiac ablation: better patient outcomes. For the first time, physicians can identify patient-specific sources that sustain serious heart rhythm disorders using the Topera Rotor Mapping Solution.